We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
(-5.3%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$472M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$63M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$61M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$56.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$107M |
| 2 |
GSK
GSK
|
+$58.9M |
| 3 |
Broadcom
AVGO
|
+$54M |
| 4 |
Unilever
UL
|
+$54M |
| 5 |
Marvell Technology
MRVL
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.5% |
| 2 | Communication Services | 3.61% |
| 3 | Financials | 3.6% |
| 4 | Healthcare | 3.01% |
| 5 | Consumer Discretionary | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
GitLab
GTLB
$5.55B
| $2.08M | 0.02% |
+37,000
| New | +$2.16M |
|
|
AXON
552
PUT
Axon Enterprise
AXON
$42.4B
| $2.08M | 0.02% |
+3,500
| New | +$1.9M |
|
553
CAVA Group
CAVA
$7.52B
| $2.08M | 0.02% |
+18,396
| New | +$2.45M |
|
554
PUT
Lowe's Companies
LOW
$119B
| $2.07M | 0.02% |
8,400
-1,000
| -11% | -$267K |
|
555
Cencora
COR
$60.5B
| $2.07M | 0.02% |
+9,215
| New | +$2.17M |
|
556
Haemonetics
HAE
$3.63B
| $2.06M | 0.02% |
+26,365
| New | +$2.12M |
|
557
CALL
RH
RH
$3.4B
| $2.05M | 0.02% |
5,200
-13,700
| -72% | -$4.87M |
|
558
CALL
AT&T
T
$167B
| $2.03M | 0.02% |
89,000
-126,400
| -59% | -$2.84M |
|
559
CALL
CleanSpark
CLSK
$3.6B
| $2.03M | 0.02% |
+220,000
| New | +$2.66M |
|
560
CALL
Darling Ingredients
DAR
$9.62B
| $2.02M | 0.02% |
+60,000
| New | +$2.27M |
|
561
CALL
Viking Therapeutics
VKTX
$4.05B
| $2.01M | 0.02% |
50,000
| – | – |
|
562
Valero Energy
VLO
$90.5B
| $2M | 0.02% |
+16,333
| New | +$2.19M |
|
563
CALL
Qorvo
QRVO
$7.92B
| $1.99M | 0.02% |
28,500
| – | – |
|
564
United Airlines
UAL
$39.1B
| $1.99M | 0.02% |
20,497
+7,370
| +56% | +$623K |
|
565
PUT
MasTec
MTZ
$26.6B
| $1.99M | 0.02% |
+14,600
| New | +$1.96M |
|
|
SEM
566
DELISTED
Select Medical
SEM
| $1.97M | 0.02% |
104,464
-222,305
| -68% | -$4.29M |
|
567
CALL
Monster Beverage
MNST
$93.2B
| $1.96M | 0.02% |
37,200
| – | – |
|
568
PUT
Blackrock
BLK
$165B
| $1.95M | 0.02% |
1,900
-4,100
| -68% | -$4.16M |
|
|
INGM
569
Ingram Micro Holding
INGM
$6.72B
| $1.94M | 0.02% |
+100,000
| New | +$2.24M |
|
570
CALL
Union Pacific
UNP
$178B
| $1.94M | 0.02% |
8,500
| – | – |
|
571
PUT
Emerson Electric
EMR
$83.6B
| $1.93M | 0.02% |
15,600
| – | – |
|
572
Alcon
ALC
$32.8B
| $1.92M | 0.02% |
+22,617
| New | +$2.04M |
|
573
PUT
Arvinas
ARVN
$530M
| $1.92M | 0.02% |
100,000
| – | – |
|
574
CALL
SLB Ltd
SLB
$76.5B
| $1.92M | 0.02% |
50,000
| – | – |
|
575
Xenon Pharmaceuticals
XENE
$6.36B
| $1.91M | 0.02% |
48,668
| – | – |
|
Similar funds
AS
TI
LMR Partners's Q4 2024 Portfolio in Review
As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.
Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.
- LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
- LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
- LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
- LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
- LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
- LMR Partners opened 534 new positions and closed 613 in Q4 2024.
- LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.
Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.